ARPHA OAI-PMH Endpoint
metadata only
CC BY 4.0
Predictive value of baseline eosinophil counts for immune-related adverse events in metastatic NSCLC treated with immune checkpoint inhibitors
biomarkersimmune-checkpoint-inhibitorsimmune-related-adverse-eventsmetastatic-non-small-cell-lung-cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Immune System Regulation: Inhibitory Checkpoint Receptors#169458
- Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy#432899
- The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China#442086
- Eosinophils Endotypes in Chronic Airway Inflammatory Diseases#1094352
- A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases#812966
Record · ID 386527
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive